Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
-
Liquidia to Present at the Stifel 2024 Healthcare Conference
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 11 11 2024] - (CGWL)
-
Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1
-
AI Integration in SMBs: Balancing Fear and FOMO
-
Araris Biotech Publishes Foundational Science Behind its Novel Antibody-Drug Conjugate Platform in ChemBioChem
-
OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting
-
Synchronoss Renews Partnership with Major French Operator
-
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
mophie unveils 3-in-1 travel charger with MagSafe, plus versatile new wireless and magnetic vent mounts—bringing seamless, on-the-go power solutions for Apple users
-
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
-
Caledonia Mining Corporation Plc: Notification of relevant change to significant shareholder
-
Timus Networks Recognized as a CRN® 2024 Stellar Startup in Security
-
TradersYard’s New CEO Unveils Vision: Double User Base and Host Prestigious 2025 World Trading Championship
-
Ramsay Generale de Sante: preparatory documents availability for the 2024 General Meeting
-
Calvetti Ferguson Adds New Partner to Grow Accounting Services in Nashville
-
Hyku Biosciences Appoints John Gustofson to its Board of Directors
-
Revive Therapeutics Announces Publication Demonstrating Novel Therapeutic Approach of Psilocybin in Stroke
-
Shimmick Corporation Announces Third Quarter 2024 Results
-
Global Technologies, Ltd. Announces Its Financial Results for the Quarter Ended September 30, 2024 with Major Financial Highlights and Accomplishments
-
Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium
-
Bicara Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Cognition Therapeutics to Present at Zacks SCR Life Sciences Investor Forum
-
reAlpha Tech Corp. Announces Over 440% Increase in Revenue for the Quarter Ended September 30, 2024
-
Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs
-
Repligen Reports Third Quarter 2024 Financial Results
-
Nayax Reports Third Quarter 2024 Financial Results
-
Shimmick Announces New CEO
-
ZenaTech Announces Acquisition of Warehouse Software Companies for Integration With AI Drone Solution for Automated Inventory Management
-
Surgery Partners, Inc. Announces Third Quarter 2024 Results
-
BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights
-
Melcor Real Estate Investment Trust Recommends Unitholders Exercise Caution Regarding Coercive Mini-Tender
-
VR Resources Initiates DCIP surveys at Empire and Silverback Copper – Gold Projects in Ontario
-
Ocular Therapeutix™ Appoints Namrata Saroj, OD, as Chief Business Officer
-
Tyson Foods Reports Fourth Quarter And Fiscal 2024 Results
-
FreightCar America, Inc. Reports Third Quarter 2024 Results
-
ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting
-
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
-
COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs
-
Steakholder Foods® Secures $270,000 in Second SIIRD Grant Installment
-
ZenaTech Announces Acquisition of Warehouse Software Companies for Integration With AI Drone Solution for Automated Inventory Management
-
Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024
-
Cronos Group Reports 2024 Third Quarter Results
-
Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
BridgeBio Pharma Reports Third Quarter 2024 Financial Results and Business Update
-
23andMe Reports Second Quarter Fiscal Year 2025 Financial Results
-
Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
Red Pine Commences 2024-25 Drilling Program at the Wawa Gold Project
-
Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa
